Mark McNally

1.5k total citations
52 papers, 1.2k citations indexed

About

Mark McNally is a scholar working on Molecular Biology, Cardiology and Cardiovascular Medicine and Sociology and Political Science. According to data from OpenAlex, Mark McNally has authored 52 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Molecular Biology, 12 papers in Cardiology and Cardiovascular Medicine and 11 papers in Sociology and Political Science. Recurrent topics in Mark McNally's work include RNA Research and Splicing (22 papers), Viral Infections and Immunology Research (12 papers) and RNA and protein synthesis mechanisms (8 papers). Mark McNally is often cited by papers focused on RNA Research and Splicing (22 papers), Viral Infections and Immunology Research (12 papers) and RNA and protein synthesis mechanisms (8 papers). Mark McNally collaborates with scholars based in United States, United Kingdom and Canada. Mark McNally's co-authors include Karen Beemon, Lisa McNally, Stephen J. Free, Richard R. Gontarek, Andrew J. Mouland, Alan Cochrane, Brent L. Fogel, Luke McNally, Mette Strand and Roy Long and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nucleic Acids Research and Journal of Biological Chemistry.

In The Last Decade

Mark McNally

48 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mark McNally United States 21 921 230 179 102 93 52 1.2k
Miles K. Yamanaka United States 15 415 0.5× 159 0.7× 39 0.2× 36 0.4× 193 2.1× 19 904
Marc D. Panas Sweden 12 1.0k 1.1× 137 0.6× 65 0.4× 77 0.8× 33 0.4× 16 1.5k
Anna Greco France 19 921 1.0× 122 0.5× 45 0.3× 89 0.9× 213 2.3× 49 1.6k
André Furger United Kingdom 24 2.3k 2.4× 83 0.4× 48 0.3× 183 1.8× 139 1.5× 31 2.7k
Ilya M. Terenin Russia 26 1.7k 1.9× 488 2.1× 55 0.3× 196 1.9× 117 1.3× 54 2.0k
J. Greenwood United States 18 572 0.6× 35 0.2× 59 0.3× 60 0.6× 166 1.8× 34 1.1k
Olaf Isken Germany 17 1.3k 1.4× 318 1.4× 57 0.3× 127 1.2× 134 1.4× 27 1.8k
Naomi Bishop Australia 16 530 0.6× 78 0.3× 107 0.6× 25 0.2× 85 0.9× 24 1.1k
Yoshie Yoshikawa Japan 20 472 0.5× 65 0.3× 65 0.4× 67 0.7× 168 1.8× 64 1.4k

Countries citing papers authored by Mark McNally

Since Specialization
Citations

This map shows the geographic impact of Mark McNally's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark McNally with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark McNally more than expected).

Fields of papers citing papers by Mark McNally

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark McNally. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark McNally. The network helps show where Mark McNally may publish in the future.

Co-authorship network of co-authors of Mark McNally

This figure shows the co-authorship network connecting the top 25 collaborators of Mark McNally. A scholar is included among the top collaborators of Mark McNally based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark McNally. Mark McNally is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Olson, Jessica, et al.. (2018). More than a Conversation: the Power of Bringing Scientists and the Community Together to Change Perceptions About Cancer. Journal of Cancer Education. 34(3). 571–576. 1 indexed citations
2.
McNally, Mark. (2017). Like No Other. University of Hawaii Press eBooks.
4.
Runge, Christina L., Christy B. Erbe, Mark McNally, et al.. (2013). A Novel Otoferlin Splice-Site Mutation in Siblings with Auditory Neuropathy Spectrum Disorder. Audiology and Neurotology. 18(6). 374–382. 17 indexed citations
5.
McNally, Mark, et al.. (2008). Characterization of Rous sarcoma virus polyadenylation site use in vitro. Virology. 374(2). 468–476. 11 indexed citations
6.
McNally, Mark. (2008). The Nanking Atrocity: Complicating the Picture. History Reviews of New Books. 36(3). 111–112. 7 indexed citations
7.
Cochrane, Alan, Mark McNally, & Andrew J. Mouland. (2006). The retrovirus RNA trafficking granule: from birth to maturity. Retrovirology. 3(1). 18–18. 100 indexed citations
8.
McNally, Mark. (2005). Proving the Way. Harvard University Asia Center eBooks. 3 indexed citations
9.
McNally, Lisa, et al.. (2005). Heterogeneous Nuclear Ribonucleoprotein H Is Required for Optimal U11 Small Nuclear Ribonucleoprotein Binding to a Retroviral RNA-processing Control Element. Journal of Biological Chemistry. 281(5). 2478–2488. 23 indexed citations
10.
McNally, Lisa, et al.. (2004). Two Regions Promote U11 Small Nuclear Ribonucleoprotein Particle Binding to a Retroviral Splicing Inhibitor Element (Negative Regulator of Splicing). Journal of Biological Chemistry. 279(37). 38201–38208. 10 indexed citations
11.
Long, Roy & Mark McNally. (2003). mRNA Decay. Molecular Cell. 11(5). 1126–1128. 25 indexed citations
12.
Fogel, Brent L. & Mark McNally. (2000). A Cellular Protein, hnRNP H, Binds to the Negative Regulator of Splicing Element from Rous Sarcoma Virus. Journal of Biological Chemistry. 275(41). 32371–32378. 51 indexed citations
13.
McNally, Lisa & Mark McNally. (1998). An RNA Splicing Enhancer-Like Sequence Is a Component of a Splicing Inhibitor Element from Rous Sarcoma Virus. Molecular and Cellular Biology. 18(6). 3103–3111. 41 indexed citations
14.
McNally, Mark, et al.. (1998). SR Protein and snRNP Requirements for Assembly of the Rous Sarcoma Virus Negative Regulator of Splicing Complexin Vitro. Virology. 242(1). 211–220. 24 indexed citations
15.
McNally, Mark, et al.. (1996). Characterization of an RNP Complex That Assembles on the Rous Sarcoma Virus Negative Regulator of Splicing Element. Nucleic Acids Research. 24(24). 4962–4968. 8 indexed citations
16.
McNally, Luke & Mark McNally. (1996). SR protein splicing factors interact with the Rous sarcoma virus negative regulator of splicing element. Journal of Virology. 70(2). 1163–1172. 55 indexed citations
18.
McNally, Mark, et al.. (1992). Induction of protective immunity in mice using a 62-kDa recombinant fragment of a Schistosoma mansoni surface antigen. The Journal of Immunology. 149(11). 3612–3620. 81 indexed citations
19.
McNally, Mark, Richard R. Gontarek, & Karen Beemon. (1991). Characterization of Rous sarcoma virus intronic sequences that negatively regulate splicing. Virology. 185(1). 99–108. 68 indexed citations
20.
McNally, Mark & Stephen J. Free. (1988). Isolation and characterization of a Neurospora glucose-repressible gene. Current Genetics. 14(6). 545–551. 86 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026